| A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy S Turongkaravee, J Jittikoon, T Lukkunaprasit, S Sangroongruangsri, ... The pharmacogenomics journal 21 (3), 296-307, 2021 | 35 | 2021 |
| Southeast asian pharmacogenomics research network (SEAPharm): current status and perspectives S Chumnumwat, ZH Lu, C Sukasem, MD Winther, FR Capule, A Hamid, ... Public health genomics 22 (3-4), 132-139, 2019 | 30 | 2019 |
| The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis T Lukkunaprasit, S Rattanasiri, S Turongkaravee, N Suvannang, ... BMC Medical Genetics 21, 1-13, 2020 | 22 | 2020 |
| Cost-utility analysis of deep learning and trained human graders for diabetic retinopathy screening in a nationwide program A Srisubat, K Kittrongsiri, S Sangroongruangsri, C Khemvaranan, ... Ophthalmology and Therapy 12 (2), 1339-1357, 2023 | 11 | 2023 |
| Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and … S Turongkaravee, J Jittikoon, O Rochanathimoke, K Boyd, O Wu, ... BMC Health Services Research 21, 1-23, 2021 | 11 | 2021 |
| Evaluation of high-cost medicine scheme (Category E2) under the 2008 National List of Essential Medicines S Turongkaravee, W Rattanavipapong, R Khampang, P Leelahavarong, ... Nonthaburi: Health Intervention and Technology Assessment Program, 2012 | 5 | 2012 |
| Economic evaluation of multiple-pharmacogenes testing for the prevention of adverse drug reactions in people living with HIV S Turongkaravee, N Praditsitthikorn, T Ngamprasertchai, J Jittikoon, ... ClinicoEconomics and Outcomes Research, 447-463, 2022 | 3 | 2022 |
| Costs Associated with Adverse Drug Reactions Among HIV/TB Patients in Thailand O Rochanathimoke, P Tragulpiankit, S Turongkaravee, J Jittikoon, ... ClinicoEconomics and Outcomes Research, 587-599, 2022 | 3 | 2022 |
| Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis S Aungsumart, S Turongkaravee, S Youngkong, M Apiwattanakul, ... BMC Health Services Research 23 (1), 1096, 2023 | 2 | 2023 |
| Economic evaluation of prenatal screening for fetal aneuploidies in Thailand P Wongkrajang, J Jittikoon, W Udomsinprasert, P Talungchit, ... Plos one 18 (9), e0291622, 2023 | 1 | 2023 |
| Economic analysis of pharmacogenetics testing for human leukocyte antigen-based adverse drug reactions R Yuliwulandari, U Chaikledkaew, K Prayuni, H Zahroh, ... Economic Evaluation in Genomic and Precision Medicine, 71-86, 2023 | 1 | 2023 |
| 300 Association between rs2231142 of ABCG2 and gout, hyperuricemia and uric acid: Systematic review and meta-analysis T Lukkunaprasit, S Rattanasiri, S Turongkaravee, A Ingsathit, J Attia, ... International Journal of Epidemiology 50 (Supplement_1), dyab168. 403, 2021 | | 2021 |
| PMH7 FACTORS ASSOCIATED WITH TOTAL TIME AND COST OF PROVIDING CARE FOR THAI PATIENTS WITH DEMENTIA U Chaikledkaew, S Turongkaravee, S Chansirikarnjana, ... Value in Health 7 (13), A554, 2010 | | 2010 |
| CE3 COST-UTILITY ANALYSIS OF CHOLINESTERASE INHIBITORS IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE S Turongkaravee Value in Health 7 (13), A502, 2010 | | 2010 |
| Cost-utility Analysis of Cholinesterase Inhibitors in the Treatment of Mild to Moderate Alzheimer's Disease S Turongkaravee Mahidol University, 2008 | | 2008 |
